These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17178260)

  • 1. Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications.
    Barnes KI; Little F; Smith PJ; Evans A; Watkins WM; White NJ
    Clin Pharmacol Ther; 2006 Dec; 80(6):582-96. PubMed ID: 17178260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic Modeling.
    Salman S; Baiwog F; Page-Sharp M; Griffin S; Karunajeewa HA; Mueller I; Rogerson SJ; Siba PM; Ilett KF; Davis TME
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic properties of azithromycin in pregnancy.
    Salman S; Rogerson SJ; Kose K; Griffin S; Gomorai S; Baiwog F; Winmai J; Kandai J; Karunajeewa HA; O'Halloran SJ; Siba P; Ilett KF; Mueller I; Davis TM
    Antimicrob Agents Chemother; 2010 Jan; 54(1):360-6. PubMed ID: 19858250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy.
    Nyunt MM; Adam I; Kayentao K; van Dijk J; Thuma P; Mauff K; Little F; Cassam Y; Guirou E; Traore B; Doumbo O; Sullivan D; Smith P; Barnes KI
    Clin Pharmacol Ther; 2010 Feb; 87(2):226-34. PubMed ID: 19776738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of plasma concentration of pyrimethamine (PYR) in infants with congenital Toxoplasma gondii infection--own observations.
    Lipka B; Milewska-Bobula B; Filipek M
    Wiad Parazytol; 2011; 57(2):87-92. PubMed ID: 21682092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of mathematical modelling to inform national malaria intervention planning in Nigeria.
    Ozodiegwu ID; Ambrose M; Galatas B; Runge M; Nandi A; Okuneye K; Dhanoa NP; Maikore I; Uhomoibhi P; Bever C; Noor A; Gerardin J
    Malar J; 2023 Apr; 22(1):137. PubMed ID: 37101146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetics of Antimalarial Naphthoquine in Combination with Artemisinin in Tanzanian Children and Adults: Dose Optimization.
    Ali AM; Gausi K; Jongo SA; Kassim KR; Mkindi C; Simon B; Mtoro AT; Juma OA; Lweno ON; Gwandu CH; Bakari BM; Mbaga TA; Milando FA; Hamad A; Shekalaghe SA; Abdulla S; Denti P; Penny MA
    Antimicrob Agents Chemother; 2022 May; 66(5):e0169621. PubMed ID: 35465706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data.
    WorldWide Antimalarial Resistance Network Falciparum Haematology Study Group
    BMC Med; 2022 Mar; 20(1):85. PubMed ID: 35249546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of SCD morbimortality in children: experience in a remote area of an African country.
    Mbiya BM; Kalombo DK; Mukendi YN; Daubie V; Mpoyi JK; Biboyi PM; Disashi GT; Gulbis B
    BMC Health Serv Res; 2021 Apr; 21(1):294. PubMed ID: 33794895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Physiologically-Based Pharmacokinetic Framework for Prediction of Drug Exposure in Malnourished Children.
    Sjögren E; Tarning J; Barnes KI; Jonsson EN
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33540928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria.
    Anyorigiya TA; Castel S; Mauff K; Atuguba F; Ogutu B; Oduro A; Dosoo D; Asante KP; Owusu-Agyei S; Dodoo A; Hodgson A; Binka F; Workman LJ; Allen EN; Denti P; Wiesner L; Barnes KI
    Malar J; 2021 Jan; 20(1):18. PubMed ID: 33407454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence and Population Pharmacokinetic Properties of Amodiaquine When Used for Seasonal Malaria Chemoprevention in African Children.
    Ding J; Coldiron ME; Assao B; Guindo O; Blessborn D; Winterberg M; Grais RF; Koscalova A; Langendorf C; Tarning J
    Clin Pharmacol Ther; 2020 May; 107(5):1179-1188. PubMed ID: 31652336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing.
    Ali AM; Penny MA; Smith TA; Workman L; Sasi P; Adjei GO; Aweeka F; Kiechel JR; Jullien V; Rijken MJ; McGready R; Mwesigwa J; Kristensen K; Stepniewska K; Tarning J; Barnes KI; Denti P;
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30038039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs in Development for Malaria.
    Ashley EA; Phyo AP
    Drugs; 2018 Jun; 78(9):861-879. PubMed ID: 29802605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the Use of Primaquine for the Radical Cure of Plasmodium vivax.
    Price RN; Douglas NM
    Clin Infect Dis; 2018 Sep; 67(7):1008-1009. PubMed ID: 29590343
    [No Abstract]   [Full Text] [Related]  

  • 16. Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated Malaria.
    de Kock M; Tarning J; Workman L; Allen EN; Tekete MM; Djimde AA; Bell DJ; Ward SA; Barnes KI; Denti P
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates.
    van der Velden M; Bilos A; van den Heuvel JJMW; Rijpma SR; Hurkmans EGE; Sauerwein RW; Russel FGM; Koenderink JB
    Malar J; 2017 Oct; 16(1):422. PubMed ID: 29061131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review.
    Ben-Harari RR; Goodwin E; Casoy J
    Drugs R D; 2017 Dec; 17(4):523-544. PubMed ID: 28879584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Clinical Pharmacokinetic Drug-Drug Interaction of Antimalarial Drugs α/β-Arteether and Sulfadoxine-Pyrimethamine.
    Chhonker YS; Bhosale VV; Sonkar SK; Chandasana H; Kumar D; Vaish S; Choudhary SC; Bhadhuria S; Sharma S; Singh RK; Jain GK; Vaish AK; Gaur SPS; Bhatta RS
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674061
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.